Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

282930313233343536

AstraZeneca reports positive results for lung cancer drug combination

17th Apr 2023 06:45

(Alliance News) - AstraZeneca PLC on Sunday announced that a phase three trial showed that its Imfinzi treatment, in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after surgery, had positive results in non-small cell lung cancer. Read More

TOP NEWS: AstraZeneca Covid antibody neutralises variants of concern

14th Apr 2023 08:24

(Alliance News) - AstraZeneca PLC on Friday said that its investigational Covid long-acting antibody AZD3152 neutralises all known variants of concern. Read More

LONDON BROKER RATINGS: Redburn likes Shell; Barclays raises Persimmon

11th Apr 2023 09:28

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday and over the long Easter weekend: Read More

TOP NEWS: Sanofi wins US drug control from AstraZeneca in Sobi deal

11th Apr 2023 08:57

(Alliance News) - AstraZeneca PLC on Tuesday said it has simplified its contract with Sanofi SA and Swedish Orphan Biovitrum, or Sobi, relating to the development and commercialisation of nirsevimab in the US, while Sanofi has also refiled its premerger form for its acquisition of Provention Bio Inc. Read More

LONDON BRIEFING: Harbour Energy, BP to team up on carbon capture

11th Apr 2023 07:55

(Alliance News) - Stocks in London are called to open higher on Tuesday, with European markets expected to begin the abbreviated week strongly following the long Easter weekend. Read More

LONDON MARKET CLOSE: Stocks end shortened week on positive note

6th Apr 2023 17:03

(Alliance News) - Stocks in London closed higher on Thursday, ahead of the long Easter weekend, defying gloomy local data as well as increasing expectations of a global economic slowdown. Read More

LONDON MARKET OPEN: European stocks edge higher in cautious trade

6th Apr 2023 08:37

(Alliance News) - Stock prices in London opened higher on Thursday, but sentiment was fragile amid fears of an economic slowdown in the US, and heightened geopolitical tensions. Read More

TOP NEWS: AstraZeneca's cancer drug Lynparza approved by NHS England

6th Apr 2023 07:55

(Alliance News) - The NHS has approved the use of a drug by AstraZeneca PLC which could benefit hundreds of patients with breast cancer and prostate cancer. Read More

LONDON MARKET CLOSE: Risk-off mood prevails but FTSE 100 outperforms

5th Apr 2023 17:01

(Alliance News) - Stocks in London closed largely lower on Wednesday, while the FTSE 100 ended in the green thanks to a solid performance from utility and pharmaceutical stocks. Read More

AstraZeneca receives positive interim trial results for Imfinzi drug

5th Apr 2023 09:13

(Alliance News) - AstraZeneca PLC on Wednesday said it has received positive results from interim analysis of the DUO-O phase 3 trial of its Imfinzi drug. Read More

TOP NEWS: AstraZeneca's ultomiris recommended for EU approval

3rd Apr 2023 08:45

(Alliance News) - AstraZeneca PLC on Monday said the EU's Committee for Medicinal Products for Human Use of the European Medicine Agency recommended the approval of ultomiris for the treatment of adult patients with a form of neuromyelitis optica spectrum disorder. Read More

AstraZeneca signs exclusive global license deal with KYM Biosciences

30th Mar 2023 09:27

(Alliance News) - AstraZeneca PLC on Thursday said it has completed an exclusive global license agreement with KYM Biosciences Inc for its CMG901 treatment. Read More

LONDON BRIEFING: Stocks add to rebound; SSE ups earnings guidance

30th Mar 2023 07:57

(Alliance News) - Stocks in London are set to build on Wednesday's gains, as risk appetite recovers following the recent banking turmoil. Read More

TOP NEWS: AstraZeneca hails eplontersen; Enhertu wins another approval

27th Mar 2023 08:52

(Alliance News) - AstraZeneca PLC on Monday announced positive high-level results from its Neuro-TTRansform phase III trial for eplontersen, while Enhertu received another approval in Japan. Read More

LONDON BRIEFING: Stocks called higher as banking crisis fears ease

27th Mar 2023 07:54

(Alliance News) - Stocks in London were called to open higher on Monday, as investors look past the recent turbulence in the banking sector. Read More

TOP NEWS: AstraZeneca's Calquence receives first approval in China

23rd Mar 2023 08:58

(Alliance News) - AstraZeneca PLC on Thursday said its drug Calquence received its first approval in China, for adults with previously treated mantle cell lymphoma, a rare type of non-Hodgkin lymphoma. Read More

UK dividends calendar - next 7 days

20th Mar 2023 15:50

Read More

LONDON BROKER RATINGS: Jefferies rates Future at 'hold'; Spirent upped

15th Mar 2023 09:36

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

AstraZeneca hails trial results of cancer drugs Imfinzi and Tagrisso

9th Mar 2023 10:34

(Alliance News) - AstraZeneca PLC on Thursday hailed phase 3 trial results on its lung cancer drugs Imfinzi and Tagrisso. Read More

TOP NEWS: AstraZeneca hails Enhertu phase 2 trial results

6th Mar 2023 08:29

(Alliance News) - AstraZeneca PLC on Monday hailed phase 2 trial results of its cancer drug Enhertu, which it develops with Daiichi Sankyo Co Ltd. Read More

282930313233343536
FTSE 100 Latest
Value9,527.65
Change20.24